Fdg Pet Ct In Clinical Oncology

FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that provides both anatomic and functional information. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.

This manual presents a large collection of clinical cases in oncology with accompanying whole-body FDG PET-CT scans. The aim is to promote an integrated approach to the use of PET-CT, and detailed attention is therefore paid to the clinical history and diagnostic question. A central aspect of every clinical case described in this manual is the guidance on the clinical report, which is the official tool for communicating with both the referring physician and the person undergoing the diagnostic test; for this reason it needs to be clear, understandable, and written in shared language. The advice regarding report preparation is strongly supported by informative PET, CT, and PET-CT fused images of each disease. The book is broadly structured according to anatomic region, and a wide range of common diseases likely to be imaged using PET-CT is covered. This book will be of value to all those training or working in the field of oncology who wish to ensure that they are best placed to contextualize, interpret, and report the findings obtained with PET-CT, which can have such a dramatic impact on prognosis, therapeutic choice, and quality of life.​

This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.

This book is specifically designed to meet the needs of practicing radiologists by offering a practical, unified approach to PET-CT. It details how to effectively apply PET-CT in patient management. Written by radiologists who fully appreciate and understand both PET and CT, the book details an integrated understanding of PET-CT as a combined modality. Clinical topics include PET-CT of thoracic malignancies, melanoma, and breast cancer. In addition, the book reinforces fundamental concepts, such as the role of imaging diagnosis in disease management.

A description of positron emission tomography in the diagnosis and management of malignant tumors. Experts from Germany and the United States present basics, technical details, and clinical aspects for both standard and new PET techniques, illustrating the importance of PET in comparison to other imaging techniques. Generously supplemented with charts, tables, and illustrations, each chapter provides readers with well-delineated descriptions, from the basic technical situation through the clinical use of PET.

Praise for this book:Sure to be a hit -- just like the first edition...All the chapters are well written and the accuracy of information is impressive...[we] cannot recommend the book strongly enough.--RAD MagazineReturning in a second edition, this practical book presents oncological and nononcological applications for PET and PET/CT for the full range of scenarios frequently encountered in the professional setting. Placing special emphasis on PET/CT correlation and FDG oncological imaging, it opens with a thorough introduction to fundamental science and clinical basics. Each chapter in the Oncological Applications section of the book describes the role of PET and PET/CT in the management of specific diseases, providing succinct descriptions of indications and comparisons with other imaging modalities. Highlights: New chapters covering PET/CT for pediatric patients; the use of FDG PET in the evaluation of infection and inflammation; and the role of PET and PET/CT in radiation therapy planning; and FDG biology More than 500 high-quality images, including state-of-the-art color PET/CT images Pearls and pitfalls that emphasize critical concepts Discussion of normal variations and benign findings Thorough review of the current literature on PET/CT This compact book provides readers with the tools to sharpen their assessment and decision-making skills. Organized efficiently to enable rapid reference to key concepts, this concise text is ideal for residents and practitioners in radiology, nuclear medicine, oncology, radiation oncology, and nuclear medicine technology.

PET and PET-CT in Oncology describes the principles of positron emission tomography and is a useful resource for incorporating the technique in clinical practice. In a clear and straightforward fashion, the book offers instructive information and overviews of the basic principles of PET and PET-CT as well as the routine clinical PET scanning procedures for all important oncological indications. It is designed to serve as a reference work for specialists in nuclear medicine and radiology (including therapy planning) and for oncologists. It also provides student and physicians in other medical specialities with a general introduction to the effective integration of this modern technique into routine clinical diagnostics. Above all, this volume illustrates the importance of PET and PET-CT in comparison with other imaging techniques.

Edited, authored, and reviewed by an expert team of oncologists and nuclear physicians/radiologists, this one-of-a-kind title helps you make the most of the critical role PET/CT plays in cancer staging and therapeutic responses to individualized treatments. Drs. Mohsen Beheshti, Werner Langsteger, and Alireza Rezaee place an emphasis on cutting-edge research and evidence-based practice, ensuring that you’re up to date with every aspect of this fast-changing field. For each tumor entity, you’ll find authoritative discussions of background, pathology, common pattern of spread, TNM classification, clinical guidelines, discussion, evidence-based recommendations, key points, and pitfalls. Contains 130 teaching cases with high-quality PET/CT images. Presents clear, practical guidance from multiple experts across subspecialties: nuclear medicine, oncology, oncologic surgery, radiation oncology, and clinical research. Includes separate, comprehensive chapters on head and neck, lung, breast, esophageal/gastric, pancreas/neuroendocrine, colorectal, hepatobiliary, lymphoma, gynecologic, prostate, melanoma, and brain cancers. Features short reviews of clinical aspects of different cancers, primary diagnostic procedures, and recommendations regarding PET/CT from ESMO and NCCN. Helps to reveal positive outcomes or potential deficits or weaknesses in an individual plan of care, allowing for better outcomes in patient care, future cancer research, and application of radiotracers beyond 18F-FDG.